-
Je něco špatně v tomto záznamu ?
Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece
S. Avgeris, F. Fostira, A. Vagena, Y. Ninios, A. Delimitsou, R. Vodicka, R. Vrtel, S. Youroukos, DJ. Stravopodis, M. Vlassi, A. Astrinidis, D. Yannoukakos, GE. Voutsinas,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01 do 2019-12-31
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01 do 2019-12-31
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01
Springer Nature - nature.com Journals - Fully Open Access
od 2011-12-01
- MeSH
- delece genu MeSH
- dítě MeSH
- dospělí MeSH
- exony MeSH
- genetické asociační studie MeSH
- hamartin genetika MeSH
- lidé MeSH
- missense mutace MeSH
- mutační analýza DNA MeSH
- rodokmen MeSH
- terciární struktura proteinů MeSH
- tuberin genetika MeSH
- tuberózní skleróza genetika patologie MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Řecko MeSH
Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder causing benign tumors in the brain and other vital organs. The genes implicated in disease development are TSC1 and TSC2. Here, we have performed mutational analysis followed by a genotype-phenotype correlation study based on the clinical characteristics of the affected individuals. Twenty unrelated probands or families from Greece have been analyzed, of whom 13 had definite TSC, whereas another 7 had a possible TSC diagnosis. Using direct sequencing, we have identified pathogenic mutations in 13 patients/families (6 in TSC1 and 7 in TSC2), 5 of which were novel. The mutation identification rate for patients with definite TSC was 85%, but only 29% for the ones with a possible TSC diagnosis. Multiplex ligation-dependent probe amplification (MLPA) did not reveal any genomic rearrangements in TSC1 and TSC2 in the samples with no mutations identified. In general, TSC2 disease was more severe than TSC1, with more subependymal giant cell astrocytomas and angiomyolipomas, higher incidence of pharmacoresistant epileptic seizures, and more severe neuropsychiatric disorders. To our knowledge, this is the first comprehensive TSC1 and TSC2 mutational analysis carried out in TSC patients in Greece.
1st Department of Pediatrics Aghia Sophia Children's Hospital University of Athens Athens Greece
Children's Foundation Research Institute Memphis TN 38103 Tennessee USA
Tuberous Sclerosis Complex Center of Excellence Le Bonheur Children's Hospital
University Hospital and Palacky University Olomouc Olomouc Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035501
- 003
- CZ-PrNML
- 005
- 20191008113036.0
- 007
- ta
- 008
- 191007s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-017-16988-w $2 doi
- 035 __
- $a (PubMed)29196670
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Avgeris, Socratis $u Laboratory of Environmental Mutagenesis and Carcinogenesis, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece.
- 245 10
- $a Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece / $c S. Avgeris, F. Fostira, A. Vagena, Y. Ninios, A. Delimitsou, R. Vodicka, R. Vrtel, S. Youroukos, DJ. Stravopodis, M. Vlassi, A. Astrinidis, D. Yannoukakos, GE. Voutsinas,
- 520 9_
- $a Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder causing benign tumors in the brain and other vital organs. The genes implicated in disease development are TSC1 and TSC2. Here, we have performed mutational analysis followed by a genotype-phenotype correlation study based on the clinical characteristics of the affected individuals. Twenty unrelated probands or families from Greece have been analyzed, of whom 13 had definite TSC, whereas another 7 had a possible TSC diagnosis. Using direct sequencing, we have identified pathogenic mutations in 13 patients/families (6 in TSC1 and 7 in TSC2), 5 of which were novel. The mutation identification rate for patients with definite TSC was 85%, but only 29% for the ones with a possible TSC diagnosis. Multiplex ligation-dependent probe amplification (MLPA) did not reveal any genomic rearrangements in TSC1 and TSC2 in the samples with no mutations identified. In general, TSC2 disease was more severe than TSC1, with more subependymal giant cell astrocytomas and angiomyolipomas, higher incidence of pharmacoresistant epileptic seizures, and more severe neuropsychiatric disorders. To our knowledge, this is the first comprehensive TSC1 and TSC2 mutational analysis carried out in TSC patients in Greece.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a exony $7 D005091
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a delece genu $7 D017353
- 650 _2
- $a genetické asociační studie $7 D056726
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a missense mutace $7 D020125
- 650 _2
- $a rodokmen $7 D010375
- 650 _2
- $a terciární struktura proteinů $7 D017434
- 650 _2
- $a tuberózní skleróza $x genetika $x patologie $7 D014402
- 650 _2
- $a hamartin $x genetika $7 D000077004
- 650 _2
- $a tuberin $x genetika $7 D000077005
- 651 _2
- $a Řecko $7 D006115
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Fostira, Florentia $u Molecular Diagnostics Laboratory, INRaSTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
- 700 1_
- $a Vagena, Andromachi $u Molecular Diagnostics Laboratory, INRaSTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
- 700 1_
- $a Ninios, Yiannis $u Laboratory of Environmental Mutagenesis and Carcinogenesis, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece.
- 700 1_
- $a Delimitsou, Angeliki $u Laboratory of Environmental Mutagenesis and Carcinogenesis, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece. Molecular Diagnostics Laboratory, INRaSTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
- 700 1_
- $a Vodicka, Radek $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Vrtel, Radek $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Youroukos, Sotirios $u First Department of Pediatrics, Aghia Sophia Children's Hospital, University of Athens, Athens, Greece.
- 700 1_
- $a Stravopodis, Dimitrios J $u Section of Cell Biology and Biophysics, Department of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, Athens, Greece.
- 700 1_
- $a Vlassi, Metaxia $u Laboratory of Protein Structure and Molecular Modelling, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece.
- 700 1_
- $a Astrinidis, Aristotelis $u Division of Nephrology, Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center; Tuberous Sclerosis Complex Center of Excellence, Le Bonheur Children's Hospital; and Children's Foundation Research Institute, Memphis TN 38103, Tennessee, USA.
- 700 1_
- $a Yannoukakos, Drakoulis $u Molecular Diagnostics Laboratory, INRaSTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
- 700 1_
- $a Voutsinas, Gerassimos E $u Laboratory of Environmental Mutagenesis and Carcinogenesis, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece. mvoutsin@bio.demokritos.gr.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. 1 (2017), s. 16697
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29196670 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191008113452 $b ABA008
- 999 __
- $a ok $b bmc $g 1452161 $s 1074051
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 7 $c 1 $d 16697 $e 20171201 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20191007